Our lab and others have shown that overexpression of GATA3 in the metastatic MDA-MB-231 (MB-231) basal triple-negative breast cancer cell line reduces tumorigenesis and metastasis [5]–[7]. This evidence concerns the gene GATA3 and triple-negative breast carcinoma.